secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)
CIK:        0001500198
Form:       8-K
Filed at:   2024-03-15T23:59:59+00:00
Accession:  0001213900-24-023083
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.07, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NeuroOne shareholders elect director, ratify auditor, approve exec compensation vote every three years
--------------------------------------------------------------------------------

- Paul Buckman elected Class I director: 5,804,908 for, 1,363,109 withheld, 8,614,407 broker non-votes.
- Ratification of Baker Tilly as independent auditor: 15,736,069 for, 36,991 against, 9,364 abstain.
- Advisory approval of named executive officer compensation: 6,586,582 for, 330,506 against, 250,929 abstain.
- Advisory vote on frequency of exec compensation votes: every three years selected (3,723,836 votes); board to implement that cycle.
- 60.89% of shares represented at meeting (15,782,424 of ~25.9M shares outstanding).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1500198/000121390024023083/0001213900-24-023083-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1500198/000121390024023083/ea0201844-8k_neuroone.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-023083

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer